60 Degrees (SXTP)
1.55
0.00 (0.00%)
Latest Headlines
Form 8-K 60 DEGREES PHARMACEUTICA For: Jul 20
July 20, 2026 4:06 PM - SEC Filing
Form 8-K 60 DEGREES PHARMACEUTICA For: Jul 07
July 9, 2026 4:06 PM - SEC Filing
60 Degrees Pharma signs option deal with Florida State for tick disease compound
July 8, 2026 8:01 AM - StreetInsider
60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases
July 8, 2026 8:01 AM - Globe NewsWire
Form DEF 14A 60 DEGREES PHARMACEUTICA For: Aug 05
July 2, 2026 4:06 PM - SEC Filing
60 Degrees Pharma gets safety board clearance for babesiosis trial
July 1, 2026 8:02 AM - StreetInsider
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue
July 1, 2026 8:02 AM - Globe NewsWire
Form 4 60 DEGREES PHARMACEUTICA For: Jun 12 Filed by: DOW GEOFFREY S
June 15, 2026 4:51 PM - SEC Filing
60 Degrees Pharmaceuticals licenses Australian chestnut patent
June 11, 2026 8:03 AM - StreetInsider
60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement
June 11, 2026 8:03 AM - Globe NewsWire
Form PRE 14A 60 DEGREES PHARMACEUTICA For: Jun 08
June 8, 2026 5:14 PM - SEC Filing
Form 8-K 60 DEGREES PHARMACEUTICA For: Jun 03
June 3, 2026 4:57 PM - SEC Filing
60 Degrees Pharmaceuticals enrolls first patient in tafenoquine babesiosis trial
May 26, 2026 8:03 AM - StreetInsider
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis
May 26, 2026 8:02 AM - Globe NewsWire
H.C. Wainwright Downgrades 60 Degrees Pharmaceuticals Inc (SXTP) to Neutral
May 20, 2026 12:19 PM - StreetInsider
Form 3 60 DEGREES PHARMACEUTICA For: May 13 Filed by: Francois Eric
May 19, 2026 6:14 PM - SEC Filing
Form 8-K 60 DEGREES PHARMACEUTICA For: May 13
May 18, 2026 4:33 PM - SEC Filing
Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: Knight Therapeutics Inc.
May 15, 2026 4:05 PM - SEC Filing
Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: CVI Investments, Inc.
May 15, 2026 12:22 PM - SEC Filing
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results
May 15, 2026 8:42 AM - Globe NewsWire
Form 10-Q 60 DEGREES PHARMACEUTICA For: Mar 31
May 15, 2026 8:12 AM - SEC Filing
Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: INTRACOASTAL CAPITAL, LLC
May 13, 2026 4:31 PM - SEC Filing
Full Article List
